These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2888501)

  • 41. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients.
    Freedman R; Adler LE; Waldo MC; Pachtman E; Franks RD
    Biol Psychiatry; 1983 May; 18(5):537-51. PubMed ID: 6134559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia.
    Umbricht DS; Bates JA; Lieberman JA; Kane JM; Javitt DC
    Biol Psychiatry; 2006 Apr; 59(8):762-72. PubMed ID: 16497277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Population Pharmacokinetic/ Pharmacodynamic Modelling of Auditory-Evoked Event-Related Potentials with Lorazepam.
    Lombard A; Brittain C; Wishart G; Lowe S; McCarthy A; Landschulz W; Dorffner G; Anderer P; Yuen E
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):245-252. PubMed ID: 28869786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Auditory and visual P300 reflecting cognitive improvement in patients with schizophrenia with quetiapine: a pilot study.
    Park EJ; Han SI; Jeon YW
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):674-80. PubMed ID: 20304022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. P300 alterations in schizophrenic patients experiencing auditory hallucinations.
    Papageorgiou C; Oulis P; Vasios C; Kontopantelis E; Uzunoglu N; Rabavilas A; Christodoulou GN
    Eur Neuropsychopharmacol; 2004 May; 14(3):227-36. PubMed ID: 15056482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Normalization of auditory physiology by cigarette smoking in schizophrenic patients.
    Adler LE; Hoffer LD; Wiser A; Freedman R
    Am J Psychiatry; 1993 Dec; 150(12):1856-61. PubMed ID: 8238642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of perospirone on auditory P300 in schizophrenia: a preliminary study.
    Araki T; Kasai K; Rogers MA; Kato N; Iwanami A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1083-90. PubMed ID: 16723179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delayed visual NA potential in remitted schizophrenia: a new vulnerability marker for psychotic relapse under low-dose medication.
    Matsuoka H; Matsumoto K; Yamazaki H; Yoshida S; Numachi Y; Saito H; Ueno T; Sato M
    Biol Psychiatry; 1999 Jan; 45(1):107-15. PubMed ID: 9894582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of neuroleptic treatment on positive and negative symptoms of schizophrenia and the results of the dexamethasone test].
    Rybakowski J; Linka M
    Psychiatr Pol; 1991; 25(1):1-6. PubMed ID: 1685787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blink rate in psychiatric illness.
    Mackintosh JH; Kumar R; Kitamura T
    Br J Psychiatry; 1983 Jul; 143():55-7. PubMed ID: 6882993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. P3 reduction in auditory evoked potentials of schizophrenics.
    Roth WT; Pfefferbaum A; Horvath TB; Berger PA; Kopell BS
    Electroencephalogr Clin Neurophysiol; 1980 Sep; 49(5-6):497-505. PubMed ID: 6158431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The N2 component of the event-related potential in schizophrenic patients.
    Brecher M; Porjesz B; Begleiter H
    Electroencephalogr Clin Neurophysiol; 1987 Apr; 66(4):369-75. PubMed ID: 2435516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interpeak latency of auditory event-related potentials (P300) in senile depression and dementia of the Alzheimer type.
    Sumi N; Nan'no H; Fujimoto O; Ohta Y; Takeda M
    Psychiatry Clin Neurosci; 2000 Dec; 54(6):679-84. PubMed ID: 11145468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Auditory change detection in schizophrenia: sources of activity, related neuropsychological function and symptoms in patients with a first episode in adolescence, and patients 14 years after an adolescent illness-onset.
    Oades RD; Wild-Wall N; Juran SA; Sachsse J; Oknina LB; Röpcke B
    BMC Psychiatry; 2006 Feb; 6():7. PubMed ID: 16466573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dexamphetamine reduces auditory P3 delta power and phase-locking while increasing gamma power.
    Albrecht MA; Price G; Lee J; Iyyalol R; Martin-Iverson MT
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):734-46. PubMed ID: 22440975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiating cortical patterns of cognitive dysfunction in schizophrenia and posttraumatic stress disorder.
    Galletly CA; McFarlane AC; Clark R
    Psychiatry Res; 2008 May; 159(1-2):196-206. PubMed ID: 18423610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does electroconvulsive therapy (ECT) affect cognitive components of auditory evoked P300?
    Griskova I; Dapsys K; Andruskevicius S; Ruksenas O
    Acta Neurobiol Exp (Wars); 2005; 65(1):73-7. PubMed ID: 15794033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phoneme discrimination in schizophrenia.
    Kugler BT; Caudrey DJ
    Br J Psychiatry; 1983 Jan; 142():53-9. PubMed ID: 6831130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of duration of untreated psychosis on auditory P300 in drug-naive and first-episode schizophrenia.
    Wang J; Hirayasu Y; Hokama H; Tanaka S; Kondo T; Zhang M; Xiao Z
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):209-14. PubMed ID: 15823170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Auditory event-related potential abnormalities in bipolar disorder and schizophrenia.
    O'Donnell BF; Vohs JL; Hetrick WP; Carroll CA; Shekhar A
    Int J Psychophysiol; 2004 Jun; 53(1):45-55. PubMed ID: 15172135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.